NaaS Technology, Inc. engages in the provision of electric vehicle charging services. The firm maintains an EV charging network in China through its charging network for third-party charging station operators, and the number of public DCFCs (direct current fast charger with 30kW power output or more) connected to its network. The company was founded by Zhen Dai and Yang Wang on July 16, 2013 and is headquartered in Beijing, China.

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Zoomcar Holdings, Inc. engages in the business of owning and leasing vehicles with an online peer-to-peer car sharing platform which connects hosts with guests. The company is headquartered in Bangalore, India.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

ECARX Holdings, Inc. engages in the development of mobility technology services. The company was founded on November 12, 2019 and is headquartered in London, the United Kingdom.

Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.

Applied UV, Inc. engages the development, acquisition and commercialization of technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets. It operates through following segments: Disinfection, Hospitality, and Corporate. The Disinfection segment designs, manufactures, assembles, and distributes automated disinfecting mirror systems for use in hospitals and other healthcare facilities. The Hospitality segment manufactures fine mirrors specifically for the hospitality industry. The Corporate segment represents expenses primarily related to corporate governance, such as board fees, legal expenses, audit fees, executive management, and listing costs. The company was founded on February 26, 2019 and is headquartered in Mount Vernon, NY.

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.